What You Should Know:
- Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.
- Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know:
- Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care.
- Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer.
- This collaborative agreement combines
Read More
Using NLP Technology To Uncover Real-World Patient Insights
It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years. As difficult as it is to ignore the massive impact that connected technologies and social media have had on the way we experience our world, it’s somehow even more challenging to fully grasp the scale of it. For health researchers, this data explosion – and especially the rise
Read More
Transcarent Launches Oncology Care for Collaborative Cancer Care Experience
What You Should Know:
- Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families launches Transcarent Oncology Care, a collaborative cancer care experience that connects employees and their families with high-quality cancer care from leading cancer institutes, top-rated oncology providers and researchers, and clinical trial identification irrespective of their geographic location.
- Transcarent Oncology Care
Read More
NCODA & XIFIN Launch Initiative to Expand Oncology Patient Care Options
What You Should Know:
- XIFIN has partnered with NCODA, Inc., a globally recognized association that develops unique resources to help medically integrated oncology teams deliver top-tier care. This new strategic partnership “NCODA Informatics Initiative Powered by VisualStrata” provides the use of VisualStrata as part of the NCODA membership.
- As oncology groups work to find and secure clinical trials – thereby expanding patient care options within their practice – purpose-built
Read More
PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development
What You Should Know:
- PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs in oncology and non-alcoholic steatohepatitis (NASH).
- As part of the partnership, GSK will leverage both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better models to deliver improved treatment options for patients with cancer
Read More
Invitae Launches Genomics-Forward Digital Health Platform
What You Should Know:
- Invitae launches a seamless digital platform to enhance patient and provider experiences and further bring genetics to mainstream medicine.
- Offering seamless integrations with EHR solutions, Invitae Digital Health will provide healthcare systems with a customizable suite of tools in a single, intuitive platform.
Invitae, a San Francisco, CA, based medical genetics company, announced the launch of Invitae Digital Health—a connected
Read More
ConcertAI Raises $150M at $1.9 Billion Valuation for RWD Platform
What You Should Know:
- ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150M in Series C led by Sixth Street at a $1.9B valuation.
- From its startup just five years ago, ConcertAI has emerged as one of the fastest-growing companies providing high-value software-as-a-service (SaaS) and data solutions to life sciences and biopharma companies, leading healthcare providers, contract
Read More
COTA Promotes Miruna Sasu to President and CEO
What You Should Know:
- COTA, Inc., an oncology real-world data and analytics company, announced today that Miruna Sasu, Ph.D., MBA, has been appointed president and chief executive officer.
- Since April 2021 when she was hired as the company’s chief strategy officer, Miruna has helped spearhead a series of research collaborations focused on investigating racial disparities in cancer care and the drug development process, including partnerships with the University of Chicago
Read More
Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage
The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down.
In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry.
This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time.
Precision (or personalized)
Read More
